Four More Countries Recall Heparin

Law360, New York (March 25, 2008, 12:00 AM EDT) -- The scope of worldwide recalls of heparin widened Tuesday, as evidence of contamination reportedly led regulators in France, Italy, Denmark and Australia to recall batches of the blood thinner.

According to the Wall Street Journal, a spokesman for the European Medicines Agency, Martin Harvey-Allchurch, said the EMEA presumes the contaminant is oversulfated chondroitin sulfate, the same contaminant identified by the U.S. Food and Drug Administration identified last week in batches of heparin imported to the U.S. from Chinese suppliers.

The contaminant has been linked to 19...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.